| Alternatives to conventional antibiotics in the era of antimicrobial resistance C Ghosh, P Sarkar, R Issa, J Haldar Trends in microbiology 27 (4), 323-338, 2019 | 611 | 2019 |
| A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics P Sarkar, V Yarlagadda, C Ghosh, J Haldar Medchemcomm 8 (3), 516-533, 2017 | 205 | 2017 |
| Battle against vancomycin-resistant bacteria: recent developments in chemical strategies G Dhanda, P Sarkar, S Samaddar, J Haldar Journal of medicinal chemistry 62 (7), 3184-3205, 2018 | 104 | 2018 |
| Glycopeptide antibiotic to overcome the intrinsic resistance of Gram-negative bacteria V Yarlagadda, GB Manjunath, P Sarkar, P Akkapeddi, K Paramanandham, ... ACS infectious diseases 2 (2), 132-139, 2016 | 94 | 2016 |
| A vancomycin derivative with a pyrophosphate‐binding group: a strategy to combat vancomycin‐resistant bacteria V Yarlagadda, P Sarkar, S Samaddar, J Haldar Angewandte Chemie International Edition 55 (27), 7836-7840, 2016 | 91 | 2016 |
| Vancomycin analogue restores meropenem activity against NDM-1 Gram-negative pathogens V Yarlagadda, P Sarkar, S Samaddar, GB Manjunath, SD Mitra, ... ACS Infectious Diseases 4 (7), 1093-1101, 2018 | 44 | 2018 |
| Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria DSSM Uppu, MM Konai, P Sarkar, S Samaddar, ICM Fensterseifer, ... PLoS One 12 (8), e0183263, 2017 | 41 | 2017 |
| Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria V Yarlagadda, P Sarkar, GB Manjunath, J Haldar Bioorganic & Medicinal Chemistry Letters 25 (23), 5477-5480, 2015 | 39 | 2015 |
| l-Lysine based lipidated biphenyls as agents with anti-biofilm and anti-inflammatory properties that also inhibit intracellular bacteria C Ghosh Chemical Communications 53 (60), 8427-8430, 2017 | 34 | 2017 |
| Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy P Sarkar, S Samaddar, V Ammanathan, V Yarlagadda, C Ghosh, ... ACS Chemical Biology 15 (4), 884-889, 2020 | 32 | 2020 |
| Pursuit of next-generation glycopeptides: a journey with vancomycin Y Acharya, G Dhanda, P Sarkar, J Haldar Chemical Communications 58 (12), 1881-1897, 2022 | 24 | 2022 |
| Designing simple lipidated lysines: bifurcation imparts selective antibacterial activity C Ghosh, MM Konai, P Sarkar, S Samaddar, J Haldar ChemMedChem 11 (21), 2367-2371, 2016 | 23 | 2016 |
| Alkyl-aryl-vancomycins: multimodal glycopeptides with weak dependence on the bacterial metabolic state P Sarkar, D Basak, R Mukherjee, JE Bandow, J Haldar Journal of Medicinal Chemistry 64 (14), 10185-10202, 2021 | 14 | 2021 |
| Glycopeptide antibiotics: mechanism of action and recent developments P Sarkar, J Haldar Antibiotic Drug Resistance, 73-95, 2019 | 10 | 2019 |
| Next-generation membrane-active glycopeptide antibiotics that also inhibit bacterial cell division P Sarkar, K De, M Modi, G Dhanda, RP Priyadarshini, JE Bandow, ... Chemical Science, 2023 | 4 | 2023 |
| Next-generation glycopeptide antibiotics: Designs to overcome inherited and non-inherited resistance and insights into their mechanisms of action P Sarkar Jawaharlal Nehru Centre for Advanced Scientific Research, 2021 | | 2021 |
| Development of cationic lipophilic vancomycin analogues against bacterial biofilms and intracellular pathogens P Sarkar Jawaharlal Nehru Centre for Advanced Scientific Research, 2016 | | 2016 |
Jayanta HaldarProfessor, JNCASR在 jncasr.ac.in 的电子邮件经过验证
